The influence of drug use on fall incidents among nursing home residents: a systematic review

International Psychogeriatrics
Carolyn S SterkeTischa J M van der Cammen

Abstract

Falls are a major health problem among the elderly, particularly in nursing homes. Abnormalities of balance and gait, psychoactive drug use, and dementia have been shown to contribute to fall risk. We conducted a systematic review of the literature to investigate which psychoactive drugs increase fall risk and what is known about the influence of these drugs on gait in nursing home residents with dementia. We included studies with a prospective cohort design on psychoactive drug use in nursing homes with dementia residents and with falls as an outcome measure. Seventeen studies were included in the review. Pooled risk estimates were not calculated because there was no homogeneity across studies. We assessed the strength of evidence for psychoactive drugs as a prognostic factor for falls by defining four levels of evidence: strong, moderate, limited or inconclusive. Strong evidence was defined as consistent findings (> or =80%) in at least two high quality cohorts. We found strong evidence that the use of multiple drugs (3/3 cohorts, effect sizes 1.30-1 xs 0.30), antidepressants (10/12 cohorts, effect sizes 1.10-7.60), and anti-anxiety drugs (2/2 cohorts, effect sizes 1.22-1.32) is associated with increased fall risk. The eviden...Continue Reading

References

Jul 1, 1991·Journal of Gerontology·L A LipsitzJ S Koestner
Jun 1, 1990·The Gerontologist·J N MorrisA S Friedlob
Dec 29, 1988·The New England Journal of Medicine·R S Weinstein, N H Bell
Dec 29, 1988·The New England Journal of Medicine·M E TinettiS F Ginter
Jul 1, 1987·Journal of Gerontology·J C MorrisS A Mandel
Jan 1, 1987·The Kurume Medical Journal·J TakedaT Kakegawa
Jul 15, 1995·American Journal of Epidemiology·P B ThapaW A Ray
Mar 1, 1995·British Journal of Clinical Pharmacology·S R LordJ A Ward
Mar 1, 1994·Journal of the American Geriatrics Society·S StudenskiL B Bearon
May 1, 1993·American Journal of Public Health·R Ruthazer, L A Lipsitz
Jun 1, 1996·Journal of the American Geriatrics Society·E CapezutiG Maislin
May 20, 1998·Journal of the American Geriatrics Society·D K KielyL A Lipsitz
Sep 24, 1998·The New England Journal of Medicine·P B ThapaW A Ray
Jan 27, 1999·Journal of the American Geriatrics Society·R M LeipzigM E Tinetti
Jul 15, 1999·Journal of the American Geriatrics Society·A J CampbellD M Buchner
Apr 1, 2000·Scandinavian Journal of Work, Environment & Health·G A AriënsG van der Wal
Jun 16, 2000·Occupational and Environmental Medicine·D A van der WindtA J Silman
Jun 16, 2000·Journal of the American Geriatrics Society·W A RayP Gideon
Apr 12, 2001·European Journal of Epidemiology·A Bueno-CavanillasR Gálvez-Vargas
Jul 28, 2001·BMJ : British Medical Journal·D G Altman
Apr 4, 2002·Scandinavian Journal of Public Health·Jane JensenYngve Gustafson
Oct 9, 2002·Journal of the American Geriatrics Society·Kristine E EnsrudUNKNOWN Study of Osteoporotic Fractures Research Group
Aug 2, 2003·Aging Clinical and Experimental Research·Erik RosendahlLars Nyberg
Aug 16, 2003·Journal of the American Geriatrics Society·Carol van DoornUNKNOWN Epidemiology of Dementia in Nursing Homes Research Group
Dec 23, 2003·Journal of the American Geriatrics Society·Stephen R LordPhilip N Sambrook
Jun 7, 2005·Journal of the American Geriatrics Society·Alon Y AvidanRonald D Chervin
Aug 5, 2005·Journal of the American Geriatrics Society·Le T T HienPhilip N Sambrook
Aug 31, 2006·British Journal of Clinical Pharmacology·Nathalie van der VeldeTischa J M van der Cammen
Mar 6, 2007·Journal of Clinical Nursing·Cornelia HeinzeTheo Dassen
Aug 19, 2007·Drugs & Aging·Nathalie van der VeldeTischa J M van der Cammen
Aug 24, 2007·The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists·James W CooperAllison H Burfield

❮ Previous
Next ❯

Citations

Feb 4, 2010·International Psychogeriatrics·Sofie TängmanLillemor Lundin-Olsson
Jan 17, 2013·BMC Geriatrics·Javier DamiánJesús de Pedro-Cuesta
Dec 17, 2009·BMC Health Services Research·Federico BaranziniCamilla Callegari
Sep 9, 2010·The Journal of Clinical Endocrinology and Metabolism·Michael Bliziotes
May 9, 2014·European Journal of Clinical Pharmacology·Marit Stordal BakkenSabine Ruths
Sep 8, 2010·Journal of the American Medical Directors Association·Marcos Aparecido Sarria CabreraDaniel Gonçalves de Oliveira
Jun 27, 2009·Journal des maladies vasculaires·P ManckoundiaP Pfitzenmeyer
Jul 2, 2011·Journal of Gerontological Nursing·Suzanne Fitzsimmons, Deborah Perry Schoenfelder
Aug 28, 2010·Journal of Psychosocial Nursing and Mental Health Services·Karen Van Leuven
May 24, 2011·Research in Gerontological Nursing·Julius Oluwole KehindeElaine J Amella
Jun 12, 2013·Journal of the American Geriatrics Society·Gianluigi GaliziaAntonio Nardone
Apr 11, 2012·British Journal of Clinical Pharmacology·Carolyn S SterkeTischa J M van der Cammen
May 5, 2011·Journal of Psychiatric and Mental Health Nursing·B Stubbs
Mar 12, 2011·Human Psychopharmacology·Majda AzermaiRobert Vander Stichele
Jun 2, 2011·Journal of Clinical Pharmacology·Carolyn S SterkeTischa J M van der Cammen
Jun 9, 2011·Journal of the American Geriatrics Society·Dae Hyun KimSarah D Berry
Apr 17, 2012·Journal of Psychiatric and Mental Health Nursing·E Galik, B Resnick
May 1, 2013·Journal of Psychiatric Research·Chia-Hsiang ChanMei-Ling Huang
Aug 14, 2013·Disability and Rehabilitation. Assistive Technology·Bo GlimskärTore Larsson
May 9, 2012·Journal of the American Medical Directors Association·Julie WhitneyStephen R Lord
May 29, 2016·Journal of the American Medical Directors Association·Sandra F SimmonsMelissa L McPheeters
Jul 2, 2014·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Emily Kwan, Sharon E Straus
Apr 25, 2018·Journal of the American Geriatrics Society·Ali Azeez Al-Jumaili, William R Doucette
Aug 13, 2014·Therapeutic Advances in Drug Safety·Marlies R de JongKlaas A Hartholt
May 9, 2014·Australian Health Review : a Publication of the Australian Hospital Association·Kirsten J MooreStephen D Gill
Mar 29, 2019·Pharmacoepidemiology and Drug Safety·Sarah Ahmed HamzaIbrahim Mohamed Fouad
May 30, 2019·Journal of the American Geriatrics Society·Diana M SobierajWilliam L Baker
Jun 5, 2019·Postgraduate Medicine·Raymond ParySteven Lippmann
Jan 1, 2013·Expert Review of Clinical Pharmacology·Arduino A MangoniStephen H D Jackson
Jul 6, 2019·International Clinical Psychopharmacology·Masaki ShinfukuToshiaki Kikuchi
Jul 25, 2017·Current Treatment Options in Neurology·Gilles Allali, Joe Verghese
Oct 1, 2009·Dementia & Neuropsychologia·Eliane Mayumi Kato-Narita, Marcia Radanovic
Jul 10, 2019·Dementia & Neuropsychologia·Paula Sant'AnnaAndrea Camaz Deslandes
Aug 28, 2019·Journal of Clinical Medicine·Syed Shahzad HasanZaheer-Ud-Din Babar
Jul 16, 2020·The International Journal of Pharmacy Practice·James A DesboroughDavid J Wright
Aug 14, 2020·Journal of the American Geriatrics Society·Perrine EvrardAnne Spinewine
Jan 8, 2021·International Psychogeriatrics·Dylan J JesterLadislav Volicer
Mar 30, 2021·International Journal of Geriatric Psychiatry·Stephen MacfarlaneColm Cunningham

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
Sirpa HartikainenKirsti Louhivuori
Journal of the American Geriatrics Society
Kristine E EnsrudStudy of Osteoporotic Fractures Research Group
© 2022 Meta ULC. All rights reserved